Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has shared an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that its controlling shareholder, Tianjin Pharmaceutical Holdings Co., Ltd. (TPH), has increased its stake in the company through its wholly owned subsidiary JinYao Global Pte. Ltd., which holds and trades the firm’s S-shares on the Singapore Exchange. On 4 February 2026, JinYao Global acquired 82,200 S-shares at an average price of about US$2.96 per share, lifting TPH’s overall shareholding from 42.997% to 43.008% of the company’s total issued share capital, a move that marginally consolidates the controlling shareholder’s position and may signal continued confidence in the group’s business and its Singapore-listed equity tranche.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a pharmaceutical company incorporated in the People’s Republic of China. The company issues both A-shares in the domestic Chinese market and S-shares denominated in U.S. dollars and listed on the Singapore Exchange, giving it access to both onshore and international capital markets for its pharmaceutical operations.
See more data about 2TZ stock on TipRanks’ Stock Analysis page.